Literature DB >> 11904605

Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis.

Beth A Mueller1, Juying Zhang, Cathy W Critchlow.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether women with multiple sclerosis who deliver singleton infants are more likely to have pregnancy or delivery complications or to have infants with low birth weight, preterm gestation, or malformations than women without multiple sclerosis and to compare their need for rehospitalization during the 2 years after delivery. STUDY
DESIGN: This was a population-based cohort study that used Washington State linked birth certificate-hospital discharge records for singleton births from 1987 through 1996. Pregnancy course, birth outcomes, and need for rehospitalization within 2 years after delivery were compared for 198 women with multiple sclerosis and a comparison group of 1584 women.
RESULTS: With the exception of maternal anemia, women with multiple sclerosis were no more likely to have pregnancy or delivery complications, nor were their infants more likely to be low birth weight or preterm or to have malformations. Affected women were, however, twice as likely to be rehospitalized during the 3 months after delivery.
CONCLUSION: The increased risk of rehospitalization emphasizes a need for strong support systems and close monitoring during the 3 months after delivery.

Entities:  

Mesh:

Year:  2002        PMID: 11904605     DOI: 10.1067/mob.2002.120502

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach.

Authors:  Maria Pia Amato; Antonio Bertolotto; Roberto Brunelli; Paola Cavalla; Benedetta Goretti; Maria Giovanna Marrosu; Francesco Patti; Carlo Pozzilli; Leandro Provinciali; Nicola Rizzo; Nicola Strobelt; Gioacchino Tedeschi; Maria Trojano; Giancarlo Comi
Journal:  Neurol Sci       Date:  2017-08-02       Impact factor: 3.307

Review 2.  Intravenous immunoglobulin therapy in neurological diseases during pregnancy.

Authors:  Isabel Ringel; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

3.  Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis.

Authors:  Julie Dahl; Kjell-Morten Myhr; Anne Kjersti Daltveit; Nils Erik Gilhus
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

Review 4.  Pregnancy and multiple sclerosis.

Authors:  Laura Airas; Risto Kaaja
Journal:  Obstet Med       Date:  2012-05-29

5.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

Review 6.  Caring for Women with Multiple Sclerosis Across the Lifespan.

Authors:  Kelsey Rankin; Riley Bove
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 7.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

8.  Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.

Authors:  Goeril Karlsson; Gordon Francis; Gideon Koren; Peter Heining; Xiaoli Zhang; Jeffrey A Cohen; Ludwig Kappos; William Collins
Journal:  Neurology       Date:  2014-01-24       Impact factor: 9.910

9.  Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

Authors:  F Patti; T Cavallaro; S Lo Fermo; A Nicoletti; V Cimino; R Vecchio; P Laisa; R Zarbo; M Zappia
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

Review 10.  [Pregnancy and immunomodulatory therapy in multiple sclerosis patients].

Authors:  L A Hoffmann; T Kümpfel; I Heer; R Hohlfeld
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.